Semax
Research Reliability -
A Russian-developed ACTH-fragment peptide studied for neuroprotection and cognitive support, approved as a drug only in Russia.
Appetite
Mood
Sleep
Semax
Description
Semax is a synthetic peptide derived from a fragment of ACTH (adrenocorticotropic hormone) developed in Russia, where it is approved as a prescription nasal spray for conditions like stroke recovery and ADHD-adjacent attention difficulties. Its proposed mechanisms involve BDNF upregulation and modulation of the dopaminergic and serotonergic systems, generating crossover interest from the biohacking nootropics community for focus and mood. Outside Russia, it holds no drug approval and is sold strictly as a Research Use Only chemical, meaning consistency, purity, and even accurate concentration in vendor products are unverified and use carries genuine uncertainty beyond the compound's own research profile.
Effects
First dose
subtle focus or mood lift within minutes to hours (intranasal)
Same day
short-acting
Note
research use only, under qualified guidance
How it Feels
Delivered intranasally, some users report a mild lift in focus, motivation, or mood within minutes to hours, though effects are subtle and individual. It sits in research territory with limited Western availability and oversight. Treat it as experimental rather than established.
Usage
Entry Dose
Research use only — not a self-administered OTC supplement
Standard Dose
Research protocols use intranasal delivery, under qualified medical guidance only
Max Dose
Set by prescribing physician/researcher
Onset
Minutes–hours (acute reports)
Combinations
Pairs well with
Synergistic
No well-established synergistic pairings — given the limited independent Western research base
Avoid combining
Contraindicated
Self-sourcing from unverified online vendors — purity and actual content frequently unverifiable
Use outside a qualified research or medical context — not recommended
Existing seizure disorders — ACTH-pathway peptides carry theoretical neurological caution
Biomarkers to Track
Subjective
(Daily)
Mental clarity and mood (1–10)
Anxiety levels
Sleep quality
Objective
(Quarterly)
Cognitive testing battery (attention, working memory)
No standardized clinical biomarker for at-home tracking
A research peptide with limited Western data and oversight. Effects are subtle and individual.
Anyone wanting established safety, and pregnant women.
Sourcing it from unverified vendors, and expecting strong or reliable effects.
Preliminary (limited / small human data)
Available human evidence comes from a Russian clinical research network of variable, independently unverified quality; there is no confirmed independent Western RCT. Semax is not FDA-approved and is used entirely off-label in the US.
Human clinical literature on Semax is predominantly Russian-language (e.g., stroke and BDNF-related research); specific identifiers could not be independently verified against PubMed during this review.